iShares Biotechnology ETF (IBB)
| 123.41 Delayed Data As of 5:34pm ET |  -2.69 / -2.13%Today’s Change | 122.94 Today|||52-Week Range 177.37 | -19.14% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Quattro Financial Advisors Llc Buys iShares Short Treasury Bond ETF, BTC iShares Currency ... 3:38pm / GuruFocus News - Paid Partner Content | Bond & Devick Financial Network, Inc. ... Jan 24 / GuruFocus News - Paid Partner Content |
| Johnson & Johnson Hunting for Biotech, Medical Device Acquisitions 2:57pm / GuruFocus News - Paid Partner Content | Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? Jan 17 / Zacks.com - Paid Partner Content |
| Altfest L J & Co Inc Buys iShares 0-5 Year TIPS Bond ETF, ISHARES TRUST, iShares U.S. ... Jan 24 / GuruFocus News - Paid Partner Content |
Performance
| 1 month | -18.52% | 3 years | +5.06% | |
| 3 months | -21.19% | 5 years | +7.11% | |
| 1 year | -23.27% | Since inception | +6.72% |
Data through 01/27/2022
Quote Details
| Previous close | $126.10 |
| Open day’s range | 123.41 – 127.82 |
| Net asset value (NAV) | 126.11 (01/26/2022) |
| Daily volume | 411,163 |
| Average volume (3 months) | 2,343,312 |
Data as of 5:34pm ET, 01/27/2022
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +7.11% | +15.55% |
| Expense Gross exp ratio | 0.45% | 1.01% |
| Risk 5 year sharpe ratio | 0.60 | 0.85 |
| Net assets | $10.0B | $2.3B |
| Average market cap | $20.1B | $37.5B |
| Average P/E | 19.4 | 23.2 |
| Dividend / Share | -- | 0.29% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| RYH Invesco S&P 500® Equal Weight Health Ca... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 9.13% |
| GILD Gilead Sciences | 7.13% |
| MRNA Moderna Inc | 5.82% |
| REGN Regeneron Pharmaceuticals | 5.08% |
| VRTX Vertex Pharmaceuticals Inc | 4.35% |
| ILMN Illumina Inc | 4.20% |
| IQV IQVIA Holdings Inc | 4.18% |
| BNTX BioNTech SE | 3.13% |
| MTD Mettler-Toledo International Inc | 3.01% |
| BIIB Biogen | 2.75% |
